Notice of Results and Investor Presentation
22 September 2021
Microsaic Systems plc
("Microsaic" or "Company")
Notice of Results and Investor Presentation
Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, announces that it intends to publish its interim results for the six months ended 30 June 2021 (the "Interim Results") on 27 September 2021.
Glenn Tracey, CEO, and Bevan Metcalf, FD, will provide a live presentation relating to the Interim Results via the Investor Meet Company platform on 27 September 2021 at 10:00 am BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9.00 am BST the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Microsaic Systems plc via:
https://www.investormeetcompany.com/microsaic-systems-plc/register-investor
Investors who already follow Microsaic Systems plc on the Investor Meet Company platform will automatically be invited.
|
Enquiries: |
|
|
|
|
Microsaic Systems plc Glenn Tracey, CEO Bevan Metcalf, FD
|
+44 (0)1483 751 577 |
|
|
|
Singer Capital Markets
|
+44 (0)20 7496 3000 |
|
|
|
Aubrey Powell / George Tzimas / Tom Salvesen
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Turner Pope Investments (TPI) Limited
Andy Thacker / James Pope |
+44 (0) 20 3657 0050 |
|
|
|
|
|
|
|
About Microsaic ( www.microsaic.com )
Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested £30m over the last 20 years before and after the IPO, Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.
Microsaic's products and systems are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point-of-need applications.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 hour ago Rathbones Group
- 1 hour ago Sage Group
- 1 hour ago Rathbones Group
- 1 hour ago Sage Group
- 1 hour ago Kavango Resources